Bioactive Compounds
-
BA2250 ClesrovimabSummary: Clesrovimab (MK1654) is a fully human anti-fusion (RSVF) glycoprotein monoclonal antibody. - BA2249 AVG-233Summary: AVG-233 is an orally effective RNA-dependent RNA polymerase inhibitor.
- BA2248 RSV604Summary: RSV604 (A-60444) is an inhibitor of respiratory syncytial virus replication.
- BA2247 PC786Summary: PC786 is an inhaled respiratory syncytial virus L protein polymerase inhibitor.
- BA2246 PresatovirSummary: Presatovir (GS-5806) is a potent, orally active fusion inhibitor.
- BA2245 SisunatovirSummary: Sisunatovir (RV521) is an oral fusion protein inhibitor with potent efficacy against a panel of clinically isolated RSV-A and RSV-B viruses.
- BA2244 ALS-8112Summary: ALS-8112 is a potent, selective inhibitor of respiratory syncytial virus polymerase.
- BA2243 ZiresovirSummary: Ziresovir (AK0529; RO-0529) is an orally effective, selective respiratory syncytial virus (RSV) fusion (F) protein inhibitor.
- BA2241 R-10015Summary: R-10015, a broad-spectrum antiviral compound for infections, is a highly potent and selective inhibitor that blocks LIMK by binding to the ATP-binding pocket.
- BA2240 OxamniquineSummary: An effective anti-schistosomiasis reagent.